Xconomy | Seattle - Business + Technology in the Exponential Economy

Biotech, Finances, Genomics

ISB Nabs $8M for Cancer Genome

Luke Timmerman 11/10/09

The Institute for Systems Biology, a Seattle-based nonprofit research center, said today it has secured an $8 million grant from the National Institutes of Health as part of The Cancer Genome Atlas, an effort to identify new targets for cancer drugs based on deeper genomic understanding. ISB professor Ilya Shmulevich is the co-primary investigator on the grant along with Wei Zhang of M.D. Anderson Cancer Center in Houston. Other centers receiving federal grants for the cancer genome include the Broad Institute of Harvard and MIT; Lawrence Berkeley National Laboratory; and Memorial Sloan-Kettering Cancer Center.

Luke Timmerman is the National Biotechnology Editor for Xconomy. You can e-mail him at ltimmerman@xconomy.com, call 206-624-2374, or follow him on Twitter at http://twitter.com/ldtimmerman.


Links to This Post

Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.